OCTOBER 2019CIOAPPLICATIONS.COM6Copyright © 2019 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.October - 01, 2019, Volume 05 - Issue 53 (ISSN 2644-240X) Published by ValleyMedia, Inc. To subscribe to CIO ApplicationsVisit www.cioapplications.com Managing EditorJoe Phillip*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffSalesSebastian Jacobsebastian@cioapplications.comEmailsales@cioapplications.comeditor@cioapplications.commarketing@cioapplications.comContact UsPhone: 510.330.5174Fax: 510.894.8405EditorialThe New Age of BioinformaticsInnovation in production technologies is paramount in the bioinformatics industry. It requires robust tools to advance biomedical research and development, and have a more profound impact on human health, environment, agriculture, energy, and biotechnology. This, in conjunction with an ever-growing influx of data, means that the global bioinformatics market will grow substantially in the near future. Several factors contribute to the growing acceptance of bioinformatics-- from the increasing demand for nucleic acid and protein sequencing to the successive initiatives from organizations. Broadly speaking, these include gene associating studies, a reduction in sequencing cost, and the increase in demand for applications of proteomics, genomics, and differentially expressed genes. Also, drug discovery and development, and initiatives from government and private organizations are expected to provide favorable conditions for market growth during the forecast period.Further, the support provided by bioinformatics for the development of personalized medicine and clinical diagnostics and the accumulation of high-throughput biological data in the genomic field will also make it a priority for companies. In this scenario, technical advancements in gathering and accessing ever-increasing biological information and the advent of next-generation sequencing (NGS) technology have led to the development of innovative bioinformatics tools that can analyze significant amounts of data. These tools promote data-driven decisions by helping companies analyze, store, and integrate heterogeneous data sources. But, for effective biological data integration, algorithm development, bioinformatics analysis pipeline implementation, and automation, companies require efficient, all-encompassing bioinformatics solutions.Collaboration between companies and research institutes, as well as the rising popularity of personalized medicine, are all set to provide new opportunities to the players in the bioinformatics market. In the wake of technological advancements--owing to the growing acceptance of bioinformatics tools in clinical and pharmaceutical applications--the medical biotechnology segment is also expected to undergo radical changes. In an effort to bring out a comprehensive picture of the bioinformatics arena and the recent developments in this field, we present to you insights from industry leaders and key disruptors.Let us know your thoughts.Joe PhillipManaging Editoreditor@cioapplications.comJoe PhillipGraphics & ArtJohn WalterEditorial StaffBen JacksonDaniel HolmesEzra BenjaminSai MohanRose DcruzSenior WritersClara MathewLeah JaneRoyce D'Souza
< Page 5 | Page 7 >